glp-1 for mcas GLP-1s in with Dr. Tania Dempsey - Mast Cell Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast Mast Cell Activation Syndrome (MCAS)
Description
Choosing between Mounjaro and Wegovy
When cultured human L-cells were deprived overnight of glucose and serum and then exposed to high glucose, 10% FBS, and -carrageenan (1g/ml) for 10minutes, 1h, and 24h, mRNA expression of proglucagon and secretion of GLP-1 were significantly reduced, compared to control cells not exposed to carrageenan

extending into the early 2030s, Novo Nordisk's core semaglutide patent has lapsed in Canada

Kicking off the forum, Kat Cole spoke on a panel exploring the intersection of metabolic hormones, patient experience, and market innovation
An editorial review of Bioverse: program structure, compounded-pharmacy pathway, pricing, and safety considerations

Our licensed providers create custom treatment plans based on your unique goals and health history, with ongoing telehealth support every step of the way
